Proposal Brief
Industry
Pharmaceuticals
Sub Industry
Pharmaceutical Manufacturing (Bulk Drug & API)
Deal Size
INR 50 - 300 Cr
Preferred Location
India
Region
Across India
Looking to acquire
B2B, B2C Manufacturing businesses (Own Brand & Contract Manufacturing)
Open for Distressed Assets
No
Target Requirement
The investor is seeking to acquire a majority stake or strategic position in profitable and scalable manufacturing businesses operating in the Specialty Chemicals and Active Pharmaceutical Ingredients (API) sector.
The focus is on founder-run companies with a proven track record that may be facing succession planning challenges, offering clear opportunities for operational scaling, professionalization, and long-term value creation.
Sector & Product Requirements:
- Specialty Chemicals Manufacturing
- Active Pharmaceutical Ingredients (APIs)
- Pharmaceutical Intermediates
- Custom Synthesis & Contract Manufacturing
Operational Characteristics:
- Founder-run company with established reputation
- Scalable manufacturing infrastructure
- Quality certifications (ISO, GMP, WHO-GMP, USFDA)
Succession Planning Challenges:
- Aging promoters seeking exit or reduced involvement
- Next generation not interested in continuing business
- Capital requirements for next phase of growth
Specialty Chemical Segments:
- Advanced pharmaceutical intermediates
- Fine chemicals for pharma applications
- Chiral compounds and building blocks
- Heterocyclic compounds
- Fluorochemicals for pharma
- Contract research & manufacturing (CRAMS)
- Process chemistry and scale-up service
Geographic Preferences:
- Western India - Gujarat, Maharashtra
- Southern India - Telangana, Andhra Pradesh, Karnataka
- Other Regions - Evaluated case-by-case (Based on logistics, compliance, and market access)
